Table 4.
Distribution of detected MBLs and ESBLs genotypes.
| Type of Infection | β-Lactam Resistant Isolates N |
blaNDM | blaTEM | blaCTX-M | blaSHV | blaIMP | aac-(6′)-Ib-cr |
|---|---|---|---|---|---|---|---|
| N (%) * | N (%) * | N (%) * | N (%) * | N (%) * | N (%) * | ||
| Wound infections | 25 | 14 (56%) |
23 (92%) |
14 (56%) |
15 (60%) |
12 (48%) |
9 (36%) |
| UTI | 28 | 17 (60.7%) |
27 (96.4%) |
11 (39.2%) |
12 (42.8%) |
16 (57%) |
6 (21%) |
| Gastro-enteritis | 15 | 1 (7.6%) |
7 (46.6%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
| Blood | 20 | 7 (35%) |
20 (100%) |
13 (65%) |
20 (100%) |
7 (35%) |
10 (50%) |
| Chest infection | 4 | 1 (25%) |
3 (75%) |
0 (0%) |
4 (100%) |
0 (0%) |
0 (0%) |
| Ear infection | 2 | 1 (50%) |
2 (100%) |
1 (50%) |
0 (0%) |
0 (0%) |
0 (0%) |
| Eye | 1 | 1 (100%) |
1 (100%) |
1 (100%) |
1 (100%) |
0 (0%) |
0 (0%) |
| Total | 95 | 42 (44.2%) |
76 (80%) |
40 (42%) |
52 (54.7%) |
35 (36.8%) |
25 (26.3%) |
| p value ** | 0.11 | <0.001 | 0.011 | <0.001 | 0.011 | 0.042 |
* percent was correlated to the total number of β-lactam resistant isolates in each type of infection. ** Significant p value at p ≤ 0.05.